FR2815228B1 - Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues - Google Patents

Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues

Info

Publication number
FR2815228B1
FR2815228B1 FR0013061A FR0013061A FR2815228B1 FR 2815228 B1 FR2815228 B1 FR 2815228B1 FR 0013061 A FR0013061 A FR 0013061A FR 0013061 A FR0013061 A FR 0013061A FR 2815228 B1 FR2815228 B1 FR 2815228B1
Authority
FR
France
Prior art keywords
dha
preparation
yellow powder
docosahexaenoic acid
powders obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0013061A
Other languages
English (en)
Other versions
FR2815228A1 (fr
Inventor
Jean Chouraqui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICRONUTRITION APPLIQUEE BIOTE
Original Assignee
MICRONUTRITION APPLIQUEE BIOTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICRONUTRITION APPLIQUEE BIOTE filed Critical MICRONUTRITION APPLIQUEE BIOTE
Priority to FR0013061A priority Critical patent/FR2815228B1/fr
Publication of FR2815228A1 publication Critical patent/FR2815228A1/fr
Application granted granted Critical
Publication of FR2815228B1 publication Critical patent/FR2815228B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A23L15/20—Addition of proteins, e.g. hydrolysates, fats, carbohydrates, natural plant hydrocolloids; Addition of animal or vegetable substances containing proteins, fats, or carbohydrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR0013061A 2000-10-12 2000-10-12 Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues Expired - Fee Related FR2815228B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0013061A FR2815228B1 (fr) 2000-10-12 2000-10-12 Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013061A FR2815228B1 (fr) 2000-10-12 2000-10-12 Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues

Publications (2)

Publication Number Publication Date
FR2815228A1 FR2815228A1 (fr) 2002-04-19
FR2815228B1 true FR2815228B1 (fr) 2003-02-07

Family

ID=8855266

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0013061A Expired - Fee Related FR2815228B1 (fr) 2000-10-12 2000-10-12 Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues

Country Status (1)

Country Link
FR (1) FR2815228B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112956A (en) * 1987-12-02 1992-05-12 The Nutrasweet Company Method for extraction of lipids and cholesterol
US5012761A (en) * 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
FR2749133A1 (fr) * 1996-06-04 1997-12-05 Pierre Moreau Obtention d'oeufs specifiquement enrichis en acide cervonique (acide docosahexaenoique ou dha). applications alimentaires, therapeutiques et industrielles de ces oeufs et de leurs extraits lipidiques
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
FR2773484B1 (fr) * 1998-01-09 2001-03-30 Pierre Moreau Nouvelles compositions a effet synergique entre micronutriments et substances d'origine vivante

Also Published As

Publication number Publication date
FR2815228A1 (fr) 2002-04-19

Similar Documents

Publication Publication Date Title
MA24469A1 (fr) Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA25087A1 (fr) Procedes et produits intermediaires pour la preparation de composes anti-cancereux
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
HUP0302499A3 (en) Pharmaceutical compositions of estrogen-cyclodextrin complexes and process for their preparation
DZ2870A1 (fr) Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
WO2001087217A3 (fr) Displacement of fastening means for making prefastened and refastenable diapers
HUP0303037A3 (en) Compounds to treat alzheimer's disease and pharmaceutical compositions containing them
HU208256B (en) Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
MA26603A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HUP0200669A3 (en) Process for producing pharmaceutical preparation for oral administration containing tolperison
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
FR2815228B1 (fr) Procede de preparation d'une poudre de jaune d'oeuf enrichie en acide docosahexaenoique (dha), a taux reduit en cholesterol, et les poudres obtenues
HUP0401325A3 (en) Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
FR2736914B1 (fr) Nouveaux derives d'acide aminophenylphosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP9802096A3 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form and process for producing it
FR2805259B1 (fr) Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP0001712A2 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them
HUP0201693A2 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative, process for producing it and its pharmaceutical composition
IL121623A (en) Process for the preparation of solid oral dosage forms comprising alendronic acid
FR2622800B1 (fr) Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede
FR2764507B1 (fr) Compositions pulverulentes de liposomes unilamellaires, leur procede de preparation et leurs applications comme complements nutritionnels et comme complements nutritionnels et comme medicaments
HUT54699A (en) Process for producing phosphonic acid derivatives of nmda antagonistic effect and pharmaceutical preparatives containing these compounds
DZ2932A1 (fr) Dérivés d'hygromycine a nouveaux, procédé pour le ur préparation et compositions pharmaceutiques lescontenant.
HUP0401912A3 (en) Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
ST Notification of lapse